Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks... Receive the the ...
The final part of any written paper should sum up everything that was mentioned in the text. It should be a defiant and resembling verbal stroke. Think of a conclusion as a beautiful bow on a wrapped ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results